Literature DB >> 33445261

Molecular Tuning of a Vitamin E-Scaffold pH-Sensitive and Reductive Cleavable Lipid-like Material for Accelerated in Vivo Hepatic siRNA Delivery.

Hidetaka Akita1, Yuki Noguchi1, Hiroto Hatakeyama1, Yusuke Sato1, Kota Tange2, Yuta Nakai2, Hideyoshi Harashima1.   

Abstract

A lipid nanoparticle (LNP) composed of a series of SS-cleavable and pH-activated lipid-like materials (ssPalm) was previously developed as a platform of a gene delivery system. A tertiary amine and disulfide bonding were employed to destabilize the endosomal membrane and for intracellular collapse. We report herein on the development of a hepatocyte-targeting siRNA carrier by the molecular tuning of the hydrophobic scaffold, and tertiary amine structures. The gene knockdown activity against a hepatocyte-specific marker (factor VII: FVII) was improved when a more fat-soluble vitamin (vitamin E) was employed as a hydrophobic scaffold. Moreover, to allow the tertiary amines to accept protons by sensing a slight change in endosomal acidification, its structural flexibility was minimized by fixing it in a piperidine structure, and the distance between the surface of the particle to the ternary amine was increased. As a result, the pKa value was increased to the approximately 6.18 depending on its distance, while the pKa reached plateau when the tertiary amine was linked by an excess number of linear carbon chains. The pH-dependent membrane destabilization activity, as assessed by a hemolysis assay, was increased in parallel with the pKa value. Moreover, the gene knockdown activity was improved in parallel with hemolytic activity. Finally, further optimization of the lipid/siRNA ratio, and the use of chemically (2'-fluoro) modified siRNA synergistically improved the gene knockdown efficacy to an effective dose (ED50) of 0.035 mg/kg. The developed ssPalm represents a promising platform for use as a hepatocyte-targeting siRNA carrier.

Entities:  

Keywords:  drug delivery system; liposomal nanoparticle; liver; siRNA

Year:  2015        PMID: 33445261     DOI: 10.1021/acsbiomaterials.5b00203

Source DB:  PubMed          Journal:  ACS Biomater Sci Eng        ISSN: 2373-9878


  3 in total

1.  mRNA-LNP vaccines tuned for systemic immunization induce strong antitumor immunity by engaging splenic immune cells.

Authors:  Sanne Bevers; Sander A A Kooijmans; Elien Van de Velde; Martijn J W Evers; Sofie Seghers; Jerney J J M Gitz-Francois; Nicky C H van Kronenburg; Marcel H A M Fens; Enrico Mastrobattista; Lucie Hassler; Helena Sork; Taavi Lehto; Kariem E Ahmed; Samir El Andaloussi; Katja Fiedler; Karine Breckpot; Michael Maes; Diane Van Hoorick; Thierry Bastogne; Raymond M Schiffelers; Stefaan De Koker
Journal:  Mol Ther       Date:  2022-07-12       Impact factor: 12.910

Review 2.  The Potential of Nanomedicine to Unlock the Limitless Applications of mRNA.

Authors:  Laura Taina-González; María de la Fuente
Journal:  Pharmaceutics       Date:  2022-02-21       Impact factor: 6.321

3.  pH-Responsive Lipid Nanoparticles Achieve Efficient mRNA Transfection in Brain Capillary Endothelial Cells.

Authors:  Yu Sakurai; Himeka Watanabe; Kazuma Nishio; Kohei Hashimoto; Atsuki Harada; Masaki Gomi; Masayoshi Suzuki; Ryotaro Oyama; Takumi Handa; Risa Sato; Hina Takeuchi; Ryoga Taira; Kenta Tezuka; Kota Tange; Yuta Nakai; Hidetaka Akita; Yasuo Uchida
Journal:  Pharmaceutics       Date:  2022-07-27       Impact factor: 6.525

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.